Nifty
Sensex
:
:
24302.15
80049.67
15.65 (0.06%)
62.87 (0.08%)

Pharmaceuticals & Drugs

Rating :
35/99

BSE: 540694 | NSE: Not Listed

52.67
03-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  51.57
  •  53.89
  •  51.57
  •  52.32
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  109
  •  4.45
  •  86.06
  •  44.49

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 68.78
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 132.29
  • N/A
  • 0.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.60%
  • 0.76%
  • 25.62%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.62
  • 11.21
  • 10.30

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.08
  • -0.29
  • -5.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
37.84
39.44
-4.06%
18.55
46.93
-60.47%
33.26
59.82
-44.40%
56.46
73.71
-23.40%
Expenses
34.48
49.72
-30.65%
20.46
44.17
-53.68%
31.60
50.17
-37.01%
49.91
61.69
-19.10%
EBITDA
3.36
-10.28
-
-1.91
2.76
-
1.66
9.65
-82.80%
6.55
12.01
-45.46%
EBIDTM
8.87%
-26.07%
-10.30%
5.87%
4.99%
16.12%
11.60%
16.30%
Other Income
0.19
9.23
-97.94%
-0.03
0.24
-
0.22
0.16
37.50%
0.32
0.09
255.56%
Interest
3.84
1.65
132.73%
2.51
3.47
-27.67%
2.29
3.31
-30.82%
2.31
3.45
-33.04%
Depreciation
2.05
3.03
-32.34%
1.91
2.13
-10.33%
2.22
2.11
5.21%
2.19
2.09
4.78%
PBT
-4.08
-5.73
-
-6.37
-2.60
-
-2.63
4.39
-
2.36
6.57
-64.08%
Tax
-0.43
-1.12
-
-0.44
-0.83
-
-0.31
1.76
-
0.61
3.07
-80.13%
PAT
-3.65
-4.61
-
-5.93
-1.78
-
-2.32
2.63
-
1.75
3.49
-49.86%
PATM
-9.64%
-11.68%
-31.97%
-3.78%
-6.97%
4.39%
3.10%
4.74%
EPS
-2.79
-3.53
-
-4.54
-1.36
-
-1.77
2.03
-
1.34
2.70
-50.37%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Net Sales
146.11
219.89
354.30
Net Sales Growth
-33.56%
-37.94%
 
Cost Of Goods Sold
95.11
150.59
227.98
Gross Profit
51.00
69.30
126.32
GP Margin
34.90%
31.52%
35.65%
Total Expenditure
136.45
205.16
286.41
Power & Fuel Cost
-
6.50
6.14
% Of Sales
-
2.96%
1.73%
Employee Cost
-
23.97
21.29
% Of Sales
-
10.90%
6.01%
Manufacturing Exp.
-
7.19
10.04
% Of Sales
-
3.27%
2.83%
General & Admin Exp.
-
4.10
6.16
% Of Sales
-
1.86%
1.74%
Selling & Distn. Exp.
-
10.45
11.84
% Of Sales
-
4.75%
3.34%
Miscellaneous Exp.
-
2.35
2.94
% Of Sales
-
1.07%
0.83%
EBITDA
9.66
14.73
67.89
EBITDA Margin
6.61%
6.70%
19.16%
Other Income
0.70
9.72
0.90
Interest
10.95
12.48
9.42
Depreciation
8.37
9.35
5.88
PBT
-10.72
2.63
53.50
Tax
-0.57
2.89
13.18
Tax Rate
5.32%
109.89%
24.64%
PAT
-10.15
-0.26
40.32
PAT before Minority Interest
-10.15
-0.26
40.32
Minority Interest
0.00
0.00
0.00
PAT Margin
-6.95%
-0.12%
11.38%
PAT Growth
0.00%
-
 
EPS
-7.75
-0.20
30.78

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Shareholder's Funds
86.22
83.77
Share Capital
13.06
10.37
Total Reserves
73.16
73.40
Non-Current Liabilities
27.08
36.69
Secured Loans
17.35
20.79
Unsecured Loans
3.18
0.84
Long Term Provisions
1.06
1.49
Current Liabilities
162.28
166.29
Trade Payables
68.19
70.63
Other Current Liabilities
31.42
29.98
Short Term Borrowings
44.93
46.58
Short Term Provisions
17.75
19.10
Total Liabilities
275.58
286.75
Net Block
88.15
92.61
Gross Block
146.86
141.97
Accumulated Depreciation
58.71
49.36
Non Current Assets
88.69
93.93
Capital Work in Progress
0.00
0.00
Non Current Investment
0.03
0.03
Long Term Loans & Adv.
0.52
0.41
Other Non Current Assets
0.00
0.88
Current Assets
185.19
192.81
Current Investments
0.00
0.00
Inventories
48.49
36.96
Sundry Debtors
83.15
102.06
Cash & Bank
6.18
6.65
Other Current Assets
47.38
1.40
Short Term Loans & Adv.
45.52
45.75
Net Current Assets
22.91
26.52
Total Assets
273.88
286.74

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Cash From Operating Activity
26.38
24.72
PBT
2.63
53.50
Adjustment
20.70
16.80
Changes in Working Capital
6.51
-45.05
Cash after chg. in Working capital
29.84
25.24
Interest Paid
0.00
0.00
Tax Paid
-3.46
-0.53
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-9.32
-44.41
Net Fixed Assets
-4.87
Net Investments
0.00
Others
-4.45
Cash from Financing Activity
-17.07
19.93
Net Cash Inflow / Outflow
-0.02
0.23
Opening Cash & Equivalents
0.35
0.11
Closing Cash & Equivalent
0.32
0.35

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Book Value (Rs.)
66.03
64.65
ROA
-0.09%
14.06%
ROE
-0.31%
48.13%
ROCE
9.53%
39.14%
Fixed Asset Turnover
1.52
2.50
Receivable days
153.71
105.14
Inventory Days
70.92
38.08
Payable days
168.23
113.08
Cash Conversion Cycle
56.40
30.13
Total Debt/Equity
0.81
0.92
Interest Cover
1.21
6.68

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.